Major depressive disorder drugs add warning for risk of rare eye disease
Drugs to treat major depressive disorder have been linked to angle-closure glaucoma, a rare type of the eye disease in which eye pressure rises very quickly, causing symptoms such as headache, eye pain, nausea, rainbows around lights at night, and
Young adults who were treated with growth hormones as children may be at greater risk for stroke
People who received growth hormones as children to treat short stature or hormone deficiency should be aware that they are at an increased risk of stroke caused by burst blood vessels when they become young adults, a team of French
New sleeping pill gets FDA approval, awaits DEA clearance
A new type of prescription sleep aid has won approval from the Food and Drug Administration (FDA) and if given clearance from the Drug Enforcement Administration (DEA) should be commercially available later this year.
Dialysis solutions recalled due to potential contamination
Baxter International is recalling two lots of Dianeal Low Calcium Peritoneal Dialysis Solution with 2.5 percent Dextrose 5000mL (Ambu-Flex II) because oxidized stainless steel, garment fiber and PVC particulate matter was present during the manufacturing process and seen floating in
AL Supreme Court rules: Brand name drug makers liable for warnings on generic drug counterparts
Makers of brand-name medications can be held liable for warnings on generic drugs even if the generic was produced by another drug company, the Alabama Supreme Court ruled. A majority of the nine-member court upheld a 2013 decision, which was
Lawsuits against Bayer alleging neurological side effects from Mirena IUD will not be centralized
Nine lawsuits against Bayer Healthcare Pharmaceuticals alleging the company’s Mirena IUD caused neurological conditions will not be consolidated into a multidistrict litigation because there are just too few to justify the motion. Plaintiffs had asked that the lawsuits be centralized
FDA approves new at-home colon cancer screening test
The Food and Drug Administration (FDA) has approved a new at-home stool sampling test that can detect colon cancer with more than 90 percent accuracy. The FDA gave unanimous approval to Exact Sciences Corp.’s Cologuard, a DNA-based test, finding it offered
Johnson and Johnson files motion to dismiss baby powder-ovarian cancer lawsuit
Johnson & Johnson filed a motion in Illinois court to dismiss a proposed class action lawsuit alleging the consumer health care company’s classic baby powder products increase the risk of ovarian cancer.
Osteoporosis drugs may not lower breast cancer risk in postmenopausal women
Osteoporosis drugs known as bisphosphonates may not help prevent breast cancer in women, a new study suggests.
Pancreatic cancer research grows as cases of the disease increase
Several organizations and philanthropies are banding together to find more effective treatments for pancreatic cancer, one of the most deadly forms of the disease.